Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Nafoxidine

Nafoxidine

Nafoxidine structure

Nafoxidine 

structure
  • CAS No:

    1845-11-0

  • Formula:

    C29H31NO2

  • Chemical Name:

    Nafoxidine

  • Synonyms:

    Pyrrolidine,1-[2-[4-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy]ethyl]-;Pyrrolidine,1-[2-[p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]ethyl]-;1-[2-[4-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy]ethyl]pyrrolidine;1-(2-[p-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]ethyl)pyrrolidine;Nafoxidine;Nafoxidene;1-[2-[4-(6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine

Description

Nafoxidine is a member of naphthalenes, a ring assembly and a member of benzenes.|Nafoxidine is a triphenylethylene nonsteroidal agent that acts as a partial estrogen antagonist. Nafoxidine competes with endogenous estrogen for binding to specific estrogen receptors. This agent also inhibits angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF); paradoxically, it may enhance angiogenesis in uterine tissue. Nafoxidine also induces oxidative stress, protein kinase C and calcium signaling. (NCI04)|An estrogen antagonist that has been used in the treatment of breast cancer.

Nafoxidine Basic Attributes

425.56200

425.56

4RIY10WM82

DTXSID7022386

C677

2933990090

Characteristics

21.70000

6.01300

1.137g/cm3

574.5ºC

176.7ºC

Drug Information

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)|Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)

Hydrochloride, Nafoxidine

Computed Properties

Molecular Weight:425.6
XLogP3:5.8
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:7
Exact Mass:425.235479232
Monoisotopic Mass:425.235479232
Topological Polar Surface Area:21.7
Heavy Atom Count:32
Complexity:611
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Learn More Other Chemicals

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.